Bluebird Bio Aktie Logo
US09609G2093
A40RV0

Bluebird Bio Aktie

Loading quotes...

Forecast

The analysts' average price target is €11.76 (+168.49%). The median is €10.74 (+145.21%).

Buy
  14
Hold
  19
Sell
  4

  • Court backs X in trademark dispute, allows Bluebird to keep bird logo and "to tweet"

    A Delaware court preliminarily found that X (formerly Twitter) is likely to retain the trademark rights in a later main proceeding, and in doing so has already protected the company against further infringements. At the same time, the start-up Bluebird may continue to use its feathered logo and the verb "to tweet" for sending messages. Judge Colm Connolly justified the injunction by saying Bluebird infringed and diluted the marks, but the court sees signs that X stopped earlier use. The main trademark trial will decide the final rights. » More on faz.net

Financials

In the last quarter, Bluebird Bio Aktie had revenue of €35.78M and net profit of -€26.87M
(EUR) March 2025
YoY
Revenue 35.78M -
Gross profit 24.47M -
Net profit -26.87M -
EBITDA -7.1M -

Fundamentals

Metric Value
Market capitalization
€41.82M
Number of shares
9.79M
52-week high/low
€24.57 - €2.75
Dividends No
Beta
0.37
P/E ratio
-0.20
PEG ratio
0.00
P/B ratio
-1.53
P/S ratio
0.58

Company profile

Name
Bluebird Bio Aktie
CEO
Andrew Obenshain
Employees 248
🍪

Parqet  uses cookies. Learn more